<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">CM</journal-id><journal-title-group><journal-title>Chinese Medicine</journal-title></journal-title-group><issn pub-type="epub">2151-1918</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/cm.2012.33023</article-id><article-id pub-id-type="publisher-id">CM-22704</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Tomato, a Potential Yin Food, Protects against Stroke
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>intanaporn</surname><given-names>Wattanathorn</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Wipawee</surname><given-names>Thukham-mee</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Supaporn</surname><given-names>Muchimapura</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Terdthai</surname><given-names>Tong-Un</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Panakaporn</surname><given-names>Wannanon</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>Department of Physiology, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand</addr-line></aff><author-notes><corresp id="cor1">* E-mail:<email>jintanapornw@yahoo.com(IW)</email>;</corresp></author-notes><pub-date pub-type="epub"><day>25</day><month>09</month><year>2012</year></pub-date><volume>03</volume><issue>03</issue><fpage>144</fpage><lpage>150</lpage><history><date date-type="received"><day>June</day>	<month>4,</month>	<year>2012</year></date><date date-type="rev-recd"><day>July</day>	<month>3,</month>	<year>2012</year>	</date><date date-type="accepted"><day>July</day>	<month>15,</month>	<year>2012</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Backgroud: Ischemic stroke is one of the challenge strategies nowadays due to the limitation of therapeutic efficacy. Yin deficiency and oxidative stress have been implicated in the mechanism of brain damage induced by cerebral ischemia. Therefore, we aimed to investigate whether tomato, a “Yang food” possessing antioxidant, may ameliorate brain damage in focal cerebral ischemia induced by right middle cerebral artery occlusion. Methods: Male rats were orally given tomato pomace (contained total phenolic compound 413.07 &#177; 34.45 mg of gallic acid equivalent/mg) at doses of 2, 19 and 50 mg/kg at a period of 2 weeks before and 3 weeks after the occlusion of right middle cerebral artery. Then, they were determined the brain ischemic volume and neurological score. Moreover, the markers of oxidative stress including malondialdehyde level and the activities of superoxide dismutase, catalase and glutathione peroxidase in hippocampus, striatum and cerebral cortex were also determined. Result: The results showed that tomato pomace could mitigate brain damage and neurological impairment. The neuroprotective mechanism might occur partly via the decreased oxidative stress. Conclusion: Tomato may provide health benefit for those who are risk for stroke. However, further researches are required.
 
</p></abstract><kwd-group><kwd>Tomato; &lt;i&gt;Lycopersicon Escalentum&lt;/i&gt;; Focal Cerebral Ischemia; Brain Damage</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Background</title><p>Stroke is a leading cause of death and functional disability in adult [<xref ref-type="bibr" rid="scirp.22704-ref1">1</xref>]. The most commonly found ischemic stroke is focal cerebral ischemia. Previous study showed that approximate the middle cerebral artery occlusion occurred in 10% - 15% of stroke patient. The cerebral ischemia has been characterized by a rapid onset of neurological injury due to interruption of blood flow to the brain [<xref ref-type="bibr" rid="scirp.22704-ref2">2</xref>]. Accumulating lines of evidence have suggested that free radicals play a significant role in the development of brain injury following cerebral ischemia [<xref ref-type="bibr" rid="scirp.22704-ref3">3</xref>]. However, stroke is divided into 2 main types according to Traditional Chinese Medicine. Excess stroke usually occurs during an activity and involves bleeding and high blood pressure or blood vessels disorders or brain tumor or trauma whereas deficiency stroke usually occurs been shown that once a stroke occurs, no pharmacological treatment has been available to prevent subsequent during quiet time and involves the blockage with blood stasis, embolisms or fat and phlegm stasis or trauma. It has brain damage, although some experimental drugs with potential promise are emerging [<xref ref-type="bibr" rid="scirp.22704-ref4">4</xref>]. Due to the limitation of stroke therapy, the development of novel protective strategy is required. Numerous approaches have been performed including complimentary alternative medicine.</p><p>Food has been long term used as medicine in Traditional Chinese Medicine (TCM) for a long time. Foods in Chinese Medicine are categorized as hot, cold or neutral foods depending on their effects on the body. “Yin foods” are cooling foods and are used to offset too much while “Yang foods” are warming foods which exert the opposite effect as mentioned earlier and neutral foods provide a balance between Yin and Yang.</p><p>According to TCM, foods which supply concentrated nutrition to maintain or improve tissue integrity, and encourage increased fluid and moisture levels are recommended for Yin deficiency disorders. Since ischemic stroke appears to be Yin deficiency and hyperactivity of yang, the beneficial effect of “Yang food” is considered [<xref ref-type="bibr" rid="scirp.22704-ref5">5</xref>].</p><p>Tomato or Lycopersicon escalentum Mill, a plant in a family of Solanaceae, is regarded as “Yin or cooling food”. In Chinese Medicine, it is believed that tomato have the effectiveness of detoxification, reducing blood pressure, preventing from cancer and aging. It is also rich in substances providing health benefits such as lycopene, phenolic compound, Vitamin A and Vitamin C [6,7]. In addition, it is also served as a major source of antioxidant [<xref ref-type="bibr" rid="scirp.22704-ref8">8</xref>]. Thus, this raised the hypothesis that the tomato, the “Yang food”, should have the capability to protect against brain damage induced by focal cerebral ischemia. To the best of our knowledge, no scientific evidence is available until now. Therefore, this study was carried out to determine the protective effect of tomato pomace powder against focal cerebral ischemia induced by middle cerebral artery occlusion.</p></sec><sec id="s2"><title>2. Methods</title><sec id="s2_1"><title>2.1. Preparation of Dried Tomato Pomace Powder</title><p>Wet tomato pomace powder consisting of tomato skins, pulp and crushed seeds that remain after the processing of tomato for juice was dried with oven at 50 degree Celsius for 2 hours. Then, it was grinded as powder and determined total phenolic compound and used as marker for quality control. The dried tomato pomace powder at the percent yield of 12.75 was kept in airtight container at room temperature until use. The administration of dried tomato pomace powder was performed using propylene glycol as vehicle.</p></sec><sec id="s2_2"><title>2.2. Determination of Total Phenolic Content</title><p>The total phenolic content of extracts was determined using to the Folin-Ciocalteu method [<xref ref-type="bibr" rid="scirp.22704-ref9">9</xref>]. The extracts were oxidized with Folin-Ciocalteu reagent, and the reaction was neutralized with sodium carbonate. The absorbance of the resulting blue color was measured at 760 nm after 60 min. Using gallic acid (GA) as standard total phenolic content (standard curve was prepared using concentrations of 2.5 - 50 mg/ml) was expressed as mg GA equivalent/mg of extract. Data reported of three replications.</p></sec><sec id="s2_3"><title>2.3. Animals</title><p>Male Wistar rats weighing 300 - 350 gm were obtained from National Laboratory Animal Center, Salaya, Nakorn Pathom, and were housed in group of 5 per cage in standard metal cages at 22˚C &#177; 2˚C on 12:12 h light-dark cycle. All animals were given access to food and water ad libitum. The experiments were performed to minimize animal suffering in accordance with the internationally accepted principles for laboratory use and care of European Community (EEC directive of 1986; 86/609/EEC). The experimental protocols were approved by the Institutional Animal Care and Use Committee.</p></sec><sec id="s2_4"><title>2.4. Experimental Protocol</title><p>In order to induce focal cerebral ischemia, all rats in this study were occluded the right middle cerebral artery occlusion (MCAO). Rats were randomly divided into various groups as described following: 1) Vehicle + MCAO; 2) Vitamin C + MCAO (Vitamin C + MCAO served as positive control); 3)-5) Tomato + MCAO (T2, T10 and T50 + MCAO). The animals in group 2) were treated with Vitamin C (250 mg/kg BW), a well known antioxidant which previously reported to exert the neuroprotective effect. The animals in group 3)-5) were treated with tomato pomace powder at doses of 2, 10 and 50 mg/kg BW respectively. The dosage range of tomato pomace powder used in this study was selected based on the previous data about the effect of tomato on the central nervous system and Vitamin C was used as positive control because it has been previously demonstrated to exert the neuroprotective effect. All administered substances used in this study were freshly prepared and used propylene glycol as vehicle.</p></sec><sec id="s2_5"><title>2.5. Focal Cerebral Ischemia Induction</title><p>All rats were fasted for 12 hr but they were allowed free access<sup> </sup>to water before surgery. Anesthesia was induced with intraperitoneal injection of thiopental sodium at dose of 50 mg/kg BW. Focal<sup> </sup>cerebral ischemia was induced by modified previous method described by Longa et al. Briefly, the right common carotid artery and the right external<sup> </sup>carotid artery were exposed through a ventral midline neck incision<sup> </sup>and were ligated proximally. A silicone coated nylon monofilament (4-0) suture<sup> </sup>(USS DG<sup>TM</sup> sutures; Tyco Healthcare group LP, Connecticut, USA) with its tip rounded by heating near a flame was inserted through an arteriectomy in the common carotid artery just below the carotid<sup> </sup>bifurcation, and then advanced into the internal carotid artery<sup> </sup>approximately 17 to 18 mm distal to the carotid bifurcation<sup> </sup>until a mild resistance was felt. Occlusion of the origins of<sup> </sup>the anterior cerebral artery, the middle cerebral artery, and the posterior communicating artery was thereby achieved. Then, the wound was sutured, the rats were returned<sup> </sup>to their cages with free access to food and water. The incision<sup> </sup>sites were infiltrated with 10% Povidone-Iodine Solution<sup> </sup>for anti-septic postoperative care.</p></sec><sec id="s2_6"><title>2.6. Determination of Infarct Volume</title><p>All animals were killed 24 hours after occlusion, and the brain was removed and sectioned at 2-mm thick. Sections were immersed in 2% TTC (2,3,5-triphenyl tetrazolium chloride) for 30 minutes at 37˚C. Images of stained sections were digitized, and infarction volumes were determined using an indirect method.</p></sec><sec id="s2_7"><title>2.7. Determination of Antioxidant Enzymes Activities</title><p>In order to determine the activities of antioxidant enzymes including superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GSH-Px), the ischemic brains tissues were weighed and homogenized with a buffer consisting of 10 mM sucrose, 10 mM Tris HCl, and 0.1 mM EDTA (pH 7.4), and then centrifuged at 3000 g for 15 min at 4˚C. The supernatant was used for bioassays. The activity of SOD was determined using a xanthine/xanthine oxidase system for production of superoxide radical and subsequent measurement of cytochrome c as a scavenger of the radicals. Optical density was determined using spectrometer (UV-1601, Shimadzu) at 550 nm. One unit of enzyme activity was defined as the quantity of SOD required to inhibit the rate of reduction of cytochrome c by 50%. SOD activity is presented as units per milligram of protein (U/mg protein). Catalase activity in the supernatant was measured by recording the rate of decrease in H<sub>2</sub>O<sub>2</sub> absorbance at 240 nm. The activity of catalase was expressed as μmol H<sub>2</sub>O<sub>2</sub>/min/mg protein. GSH-Px was determined using t-butylhydroperoxide as a substrate. The optical density was spectrophotometrically recorded at 340 nm. One unit of the enzyme was defined as micromoles (&#181;mol) of reduced nicotinamide adenine dinucleotide phosphate (NADPH) oxidized per minute. The GSH-Px activity was expressed as U/mg protein.</p></sec><sec id="s2_8"><title>2.8. Determination of the Malondialdehyde Level</title><p>Various brain brains of the rats including cerebral cortex, striatum and hippocampus were isolated and prepared as brain homogenate as mentioned earlier. Then, the level of lipid peroxidation in the brain homogenate was indirectly estimated by determining the accumulation of thiobarbituric acid reactive substances (TBARS).</p></sec><sec id="s2_9"><title>2.9. Statistical Analysis</title><p>Data were presented as mean &#177; standard error of mean (S.E.M.). The analysis was performed using one-way analysis of variance (ANOVA), followed by Dunnett’s test. All statistical results were considered significant if p-value &lt; 0.05.</p></sec></sec><sec id="s3"><title>3. Results</title><sec id="s3_1"><title>3.1. Total Phenolic Compound of Tomato Pomace Powder</title><p>The amount of total phenol was determined with the Folin-Ciocalteu reagent. Gallic acid was used as a standard compound and the total phenols were expressed as mg of Gallic acid equivalent. Phenolic compounds had been regarded as antioxidant agents which acted as free radical terminators [<xref ref-type="bibr" rid="scirp.22704-ref10">10</xref>]. It was found that the dried tomato pomace powder used in this study contained total phenolic compound at the concentration of 413.07 &#177; 34.45 mg of gallic acid equivalent/mg.</p></sec><sec id="s3_2"><title>3.2. Neuroprotective Effect of Tomato Pomace Powder</title><p><xref ref-type="fig" rid="fig1">Figure 1</xref> showed that before the induction of cerebral ischemia, no significant changes of the neurological score. All groups still showed grade 5 of the neurological score. After the induction of neurological score, all treated groups showed the reduction of neurological score. At 7 days after the occlusion of right middle cerebral artery, rats which subjected to Vitamin C treated groups significantly enhanced the neurological score (p-value &lt; 0.01)</p><p>compared to vehicle + MCAO treated group). When the treatment was prolonged further to 7 days after MCAO, all groups including both positive control and the tomato pomace treated groups showed the significant increase in neurological score (p-value &lt; 0.01, compared to vehicle + MCAO treated group). At 14 days after MCAO, the significant increased neurological scores were still observed (p-value &lt; 0.01 except Vitamin C treated group that showed p-value &lt; 0.05, compared to vehicle + MCAO treated group).</p><p>We also assessed the infarct volume of various areas supplied by the middle cerebral artery. The results showed that rats subjected to Vitamin C treatment significantly decreased the infarct volume in hippocampus and striatum (p-value &lt; 0.05 and 0.01 respectively; compared to the vehicle treated group) as shown in <xref ref-type="fig" rid="fig2">Figure 2</xref>. The rats which received tomato pomace powder at dose of 2 mg/kg BW could significantly decrease the infarct volume in both hippocampus and cerebral cortex (pvalue &lt; 0.05 all; compared to the vehicle treated group). The increasing doses of tomato pomace powder to 10 and 50 mg/kg BW could produce significant reduction of brain infarct volume only in hippocampus (p-value &lt; 0.01 all; compared to the vehicle + MCAO treated group).</p></sec></sec><sec id="s4"><title>3.3. Effect of Tomato Pomace Powder on Oxidative Damage Status</title><p>Since oxidative stress had been proposed to played the important role on the pathophysiology of brain damage induced by the occlusion of cerebral artery. It was found that although Vitamin C decreased the malondialdehyde (MDA) levels in hippocampus, striatum and cerebral cortex, no significant changes were observed. In addition, the significant reduction of MDA level in hippocampus was observed only in the rats subjected to high dose of tomato pomace powder (p-value &lt; 0.05; compared to the vehicle + MCAO treated group). The low dose treatment group significantly decreased the MDA level in both striatum and cerebral cortex (p-value &lt; 0.05, 0.01 respectively; compared to the vehicle + MCAO treated group). It was revealed that the high dose treated group also produced the significant reduction of the mentioned parameter in both areas mentioned above (p-value &lt; 0.05 all; compared to the vehicle + MCAO treated group) as shown in <xref ref-type="fig" rid="fig3">Figure 3</xref>.</p><p>We also determined the alteration of superoxide dismutase (SOD) activity in various areas and the results were shown in <xref ref-type="fig" rid="fig4">Figure 4</xref>. The present results showed that rats which received Vitamin C treatment significantly increased the activity of SOD in both hippocampus and cerebral cortex (p-value &lt; 0.05 all; compared to the vehicle + MCAO treated group). All doses of tomato pomace powder treated group could produce the significant elevation of SOD activity in hippocampus (p-value &lt; 0.05 all; compared to the vehicle + MCAO treated group) while the significant elevation of this enzyme in striatum was observed in rats subjected to both medium and high doses of tomato pomace powder treatment (p-value &lt; 0.001 all; compared to the vehicle + MCAO treated group). However, only the rats subjected to medium dose treatment significantly increased the SOD activity in cerebral cortex (p-value &lt; 0.05; compared to the vehicle + MCAO treated group).</p><p>The alteration of catalase (CAT) and glutathione peroxidase (GSH-Px) activities in various areas mentioned earlier were also investigated and all results were shown in Figures 5 and 6. Our data clearly demonstrated that the positive control treated group significantly increased the catalase activity only in striatum (p-value &lt; 0.05; compared to the vehicle + MCAO treated group) while increased the activities of glutathione peroxidase (GSHPx) in both hippocampus and cerebral cortex (p-value &lt; 0.05 all; compared to the vehicle + MCAO treated group). The rats which received tomato pomace powder at dose of 50 mg/kg BW also enhanced GSH-Px activity in cerebral cortex (p-value &lt; 0.05; compared to the vehicle + MCAO treated group).</p></sec><sec id="s5"><title>4. Discussion</title><p>In the current study, we have studied whether the tomato pomace powder can protect brain from cerebral ischemia induced by Rt. MCAO. It is well documented that permanent occlusion of middle cerebral artery (MCAO) gives rise to the neurological and histological abnormality. Our results indicated that the tomato pomace powder treatment offered the protection of various brain areas including hippocampus, striatum and cerebral cortex induced by MCAO. In accompany with the neuroprotection effect, the elevation of the activities of main scavenger enzymes, SOD and GSH-Px and the decreased MDA level were observed. It was previously demonstrated that</p><p>the imbalance between the oxidative stress formation and the cell capability to manage oxidative stress. Recent study showed that the superoxide radical (<img src="6-8801113\24aa4b7b-f256-439a-a3fb-028ff2569433.jpg" />) contributed the important role on the pathophysiology of cerebral ischemia [<xref ref-type="bibr" rid="scirp.22704-ref11">11</xref>]. Under normal circumstance, this radical was converted to H<sub>2</sub>O<sub>2</sub> by SOD and then H<sub>2</sub>O<sub>2</sub> was further detoxicated to H<sub>2</sub>O<sub>2</sub> by catalase and GSH-Px. Therefore, tomato pomace at the dosage range used in this study might exert its neuroprotective effect partly by increasing the activities of both SOD and GSH-Px resulting in the decreased oxidative stress leading to the decreased brain infarction volume of the mentioned areas and finally enhanced the neurological score.</p></sec><sec id="s6"><title>5. Conclusion</title><p>This study showed that the oral administration of tomato, a “Yin food” decreased the oxidative stress in rat brain by altering the levels of malondialdehyde but increased the activities of superoxide dismutase and glutathione peroxidase resulting in the neuroprotective effect of tomato against ischemic stroke, a Yin deficiency disorder. This implies that consumption of tomato may provide beneficial effect for those who are at risk for ischemic stroke. However, further researches are required to determine if these findings can be extended to prophylactic application tomato pomace powder for stroke.</p></sec><sec id="s7"><title>6. Acknowledgements</title><p>This study was supported in part by the National Research Council of Thailand, the North Eastern Stroke Research Group and the Integrative Complimentary Alternative Medicine, Khon Kaen University, Khon Kaen, Thailand.</p></sec><sec id="s8"><title>REFERENCES</title></sec><sec id="s9"><title>NOTES</title></sec></body><back><ref-list><title>References</title><ref id="scirp.22704-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">American Heart Association, “Heart Diseases and Stroke Statistics an Update,” American Heart Association, Dallas, 2003.</mixed-citation></ref><ref id="scirp.22704-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple"> 
K. Baker, C. B. Marcus, K. Huffman, H. Kruk, B. Malfro and S. R. Doctrow, “Synthetic Combined Superoxide Dismutase/Catalase Mimetics Are Protective as a Delayed Treatment in a Rat Stroke Model: A Key Role for Reactive Oxygen Species in Ischemic Brain Injury,” Journal of Pharmacological Experimental Therapeutic, Vol. 284, No. 1, 1998, pp. 215-221.</mixed-citation></ref><ref id="scirp.22704-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple"> 
A. R. Green and T. Ashwood, “Free Radical Trapping as a Therapeutic Approach to Neuroprotection in Stroke: Experimental and Clinical Studies with NXY-059 and Free Radical Scavengers,” Current Drug Targets—CNS &amp; Neurological Disorders, Vol. 4, No. 2, 2005, pp. 109-118. doi:10.2174/1568007053544156</mixed-citation></ref><ref id="scirp.22704-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple"> 
M. Barinaga, “Finding New Drugs to Treat Stroke,” Science, Vol. 272, No. 5262, 1996, pp. 664-666.</mixed-citation></ref><ref id="scirp.22704-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple"> 
Y. Song, J. Pei, Z. D. liu, H. Y. Li, J. W. Guo and Y. Huang, “Dynamic Changes in Traditiona Chinese Medicine Syndromes in Patients with Ischemic Stroke Treated by Acupuncture,” Zhong Xi Yi Jie He Xue Bao, Vol. 7, No. 4, 2009, pp. 334-341. doi:10.3736/jcim20090407</mixed-citation></ref><ref id="scirp.22704-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple"> 
M. L. Nguyen and S. J. Schwartz, “Lycopene: Chemical and Biological Properties,” Food Technology, Vol. 53, No. 2, 1999, pp. 38-45.</mixed-citation></ref><ref id="scirp.22704-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple"> 
J. Shi, M. Le Maguer, “Lycopene in Tomatoes: Chemical and Physical Properties Affected by Food Processing,” Critical Review of Food Science and Nutrition, Vol. 40 No. 1, 2000, pp.1-42. doi:10.1080/10408690091189275</mixed-citation></ref><ref id="scirp.22704-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple"> 
H. Wang, G. Cao and R. L. Prior, “Total Antioxidant Capacity of Fruits,” Journal of Agricultural and Food Chemistry, Vol. 44, No. 3, 1996, pp. 701-705. 
doi:10.1021/jf950579y</mixed-citation></ref><ref id="scirp.22704-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple"> 
S. K. Clinton, “Lycopene: Chemistry, Biology, and Implications for Human Health and Disease,” Nutrition Review, Vol. 56, No. 2, 1998, pp. 35-51. 
doi:10.1111/j.1753-4887.1998.tb01691.x</mixed-citation></ref><ref id="scirp.22704-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple"> 
F. Shahidi and P. K. J. P. D. Wanasundara, “Phenolic Antioxidants,” Critical Reviews in Food Science and Nutrition, Vol. 32, 1992, pp. 67-103.</mixed-citation></ref><ref id="scirp.22704-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple"> 
D. S. Warner, H. Sheng and I. Batini?-Haberle, “Oxidants, Antioxidants and the Ischemic Brain,” Journal of Experimental Biology, Vol. 207, 2004, pp. 3221-3231.</mixed-citation></ref></ref-list></back></article>